[HTML][HTML] T cells that help B cells in chronically inflamed tissues

DA Rao - Frontiers in immunology, 2018 - frontiersin.org
Frontiers in immunology, 2018frontiersin.org
Chronically inflamed tissues commonly accrue lymphocyte aggregates that facilitate local T
cell-B cell interactions. These aggregates can range from small, loosely arranged
lymphocyte clusters to large, organized ectopic lymphoid structures. In some cases, ectopic
lymphoid structures develop germinal centers that house prototypical T follicular helper (Tfh)
cells with high expression of Bcl6, CXCR5, PD-1, and ICOS. However, in many chronically
inflamed tissues, the T cells that interact with B cells show substantial differences from Tfh …
Chronically inflamed tissues commonly accrue lymphocyte aggregates that facilitate local T cell-B cell interactions. These aggregates can range from small, loosely arranged lymphocyte clusters to large, organized ectopic lymphoid structures. In some cases, ectopic lymphoid structures develop germinal centers that house prototypical T follicular helper (Tfh) cells with high expression of Bcl6, CXCR5, PD-1, and ICOS. However, in many chronically inflamed tissues, the T cells that interact with B cells show substantial differences from Tfh cells in their surface phenotypes, migratory capacity, and transcriptional regulation. This review discusses observations from multiple diseases and models in which tissue-infiltrating T cells produce factors associated with B cell help, including IL-21 and the B cell chemoattractant CXCL13, yet vary dramatically in their resemblance to Tfh cells. Particular attention is given to the PD-1hi CXCR5 Bcl6low T peripheral helper (Tph) cell population in rheumatoid arthritis, which infiltrates inflamed synovium through expression of chemokine receptors such as CCR2 and augments synovial B cell responses via CXCL13 and IL-21. The factors that regulate CD4+ T cell production of CXCL13 and IL-21 in these settings are also discussed. Understanding the range of T cell populations that can provide help to B cells within chronically inflamed tissues is essential to recognize these cells in diverse inflammatory conditions and to optimize either broad or selective therapeutic targeting of B cell-helper T cells.
Frontiers